Post Profile

IBM Watson is teaming up with Quest Diagnostics to launch IBM Watson for Genomics, a gene sequencing and Watson diagnostic analysis service to help oncologists deliver precision medicine to their patients. Together with Memorial Sloan Kettering Cancer Center (MSK), the service will provide a personalized tumor analysis of a patient’s sequenced genomic tumor that is... Read Moreread more

share

Related Posts

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of its AccuType® IL28B test for aiding in the prediction of patient response ...

Sequencing a cancer patient's genome can be a brilliant diagnostic tool because it helps doctors select the best treatment for them, researchers from Washington University School of Medicine in St. Louis wrote in JAMA (Journal of th...

Quest Diagnostics, the world's leading provider of diagnostic information services, and the University of California, San Francisco (UCSF), the nation's leading university focused exclusively on health, have formed a collaboration t...

HealthTap, the world’s largest, most trusted digital health hub and Quest Diagnostics has announced a collaboration that will enable doctors to order diagnostic testing services for patients through HealthTap’s comprehensive virtual...

Memorial Sloan Kettering Cancer Center and Quest Diagnostics announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors. The goal is to use molecular labor...